Cargando…

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

BACKGROUND: (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been used extensively to explore whether FDG Uptake can be used to provide prognostic information for esophageal cancer patients. The aim of the present review is to evaluate the literature available to date concerning t...

Descripción completa

Detalles Bibliográficos
Autores principales: Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192273/
https://www.ncbi.nlm.nih.gov/pubmed/21537872
http://dx.doi.org/10.1245/s10434-011-1732-1
_version_ 1782213735024164864
author Omloo, J. M. T.
van Heijl, M.
Hoekstra, O. S.
van Berge Henegouwen, M. I.
van Lanschot, J. J. B.
Sloof, G. W.
author_facet Omloo, J. M. T.
van Heijl, M.
Hoekstra, O. S.
van Berge Henegouwen, M. I.
van Lanschot, J. J. B.
Sloof, G. W.
author_sort Omloo, J. M. T.
collection PubMed
description BACKGROUND: (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been used extensively to explore whether FDG Uptake can be used to provide prognostic information for esophageal cancer patients. The aim of the present review is to evaluate the literature available to date concerning the potential prognostic value of FDG uptake in esophageal cancer patients, in terms of absolute pretreatment values and of decrease in FDG uptake during or after neoadjuvant therapy. METHODS: A computer-aided search of the English language literature concerning esophageal cancer and standardized uptake values was performed. This search focused on clinical studies evaluating the prognostic value of FDG uptake as an absolute value or the decrease in FDG uptake and using overall mortality and/or disease-related mortality as an end point. RESULTS: In total, 31 studies met the predefined criteria. Two main groups were identified based on the tested prognostic parameter: (1) FDG uptake and (2) decrease in FDG uptake. Most studies showed that pretreatment FDG uptake and postneoadjuvant treatment FDG uptake, as absolute values, are predictors for survival in univariate analysis. Moreover, early decrease in FDG uptake during neoadjuvant therapy is predictive for response and survival in most studies described. However, late decrease in FDG uptake after completion of neoadjuvant therapy was predictive for pathological response and survival in only 2 of 6 studies. CONCLUSIONS: Measuring decrease in FDG uptake early during neoadjuvant therapy is most appealing, moreover because the observed range of values expressed as relative decrease to discriminate responding from nonresponding patients is very small. At present inter-institutional comparison of results is difficult because several different normalization factors for FDG uptake are in use. Therefore, more research focusing on standardization of protocols and inter-institutional differences should be performed, before a PET-guided algorithm can be universally advocated.
format Online
Article
Text
id pubmed-3192273
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31922732011-10-24 FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review Omloo, J. M. T. van Heijl, M. Hoekstra, O. S. van Berge Henegouwen, M. I. van Lanschot, J. J. B. Sloof, G. W. Ann Surg Oncol Gastrointestinal Oncology BACKGROUND: (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been used extensively to explore whether FDG Uptake can be used to provide prognostic information for esophageal cancer patients. The aim of the present review is to evaluate the literature available to date concerning the potential prognostic value of FDG uptake in esophageal cancer patients, in terms of absolute pretreatment values and of decrease in FDG uptake during or after neoadjuvant therapy. METHODS: A computer-aided search of the English language literature concerning esophageal cancer and standardized uptake values was performed. This search focused on clinical studies evaluating the prognostic value of FDG uptake as an absolute value or the decrease in FDG uptake and using overall mortality and/or disease-related mortality as an end point. RESULTS: In total, 31 studies met the predefined criteria. Two main groups were identified based on the tested prognostic parameter: (1) FDG uptake and (2) decrease in FDG uptake. Most studies showed that pretreatment FDG uptake and postneoadjuvant treatment FDG uptake, as absolute values, are predictors for survival in univariate analysis. Moreover, early decrease in FDG uptake during neoadjuvant therapy is predictive for response and survival in most studies described. However, late decrease in FDG uptake after completion of neoadjuvant therapy was predictive for pathological response and survival in only 2 of 6 studies. CONCLUSIONS: Measuring decrease in FDG uptake early during neoadjuvant therapy is most appealing, moreover because the observed range of values expressed as relative decrease to discriminate responding from nonresponding patients is very small. At present inter-institutional comparison of results is difficult because several different normalization factors for FDG uptake are in use. Therefore, more research focusing on standardization of protocols and inter-institutional differences should be performed, before a PET-guided algorithm can be universally advocated. Springer-Verlag 2011-05-03 2011 /pmc/articles/PMC3192273/ /pubmed/21537872 http://dx.doi.org/10.1245/s10434-011-1732-1 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Gastrointestinal Oncology
Omloo, J. M. T.
van Heijl, M.
Hoekstra, O. S.
van Berge Henegouwen, M. I.
van Lanschot, J. J. B.
Sloof, G. W.
FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title_full FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title_fullStr FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title_full_unstemmed FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title_short FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
title_sort fdg-pet parameters as prognostic factor in esophageal cancer patients: a review
topic Gastrointestinal Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192273/
https://www.ncbi.nlm.nih.gov/pubmed/21537872
http://dx.doi.org/10.1245/s10434-011-1732-1
work_keys_str_mv AT omloojmt fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview
AT vanheijlm fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview
AT hoekstraos fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview
AT vanbergehenegouwenmi fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview
AT vanlanschotjjb fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview
AT sloofgw fdgpetparametersasprognosticfactorinesophagealcancerpatientsareview